Dexin Corporation (TPEX:3349)
Taiwan · Delayed Price · Currency is TWD 29.00
+0.20 (0.69%)
Feb 11, 2026, 1:30 PM CST
Dexin Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 540.58 | 453.99 | 387.42 | 552.01 | 1,231 | 813.46 | |
Revenue Growth (YoY) | 42.32% | 17.18% | -29.82% | -55.17% | 51.35% | 54.00% |
Cost of Revenue | 421.78 | 367.11 | 345.54 | 474.62 | 996.14 | 658.19 |
Gross Profit | 118.8 | 86.88 | 41.88 | 77.39 | 235.08 | 155.28 |
Selling, General & Admin | 74.33 | 79.23 | 81.76 | 96.15 | 115.4 | 87.59 |
Research & Development | 60.81 | 68.51 | 54.28 | 56.96 | 49.98 | 49.28 |
Operating Expenses | 136.5 | 154.42 | 155.33 | 142.23 | 165.24 | 137.06 |
Operating Income | -17.7 | -67.54 | -113.45 | -64.85 | 69.84 | 18.22 |
Interest Expense | -3.39 | -4.97 | -6.87 | -7.23 | -6.79 | -1.09 |
Interest & Investment Income | 0.97 | 1.52 | 2.22 | 0.79 | 0.11 | 0.17 |
Earnings From Equity Investments | -0.07 | -0.43 | -2.49 | -1.4 | 0.56 | -0.3 |
Currency Exchange Gain (Loss) | -11.19 | 13.97 | -0.24 | 18.21 | -4.98 | -9.55 |
Other Non Operating Income (Expenses) | 8.64 | 10.78 | 9.42 | 8.57 | 11.83 | 13.99 |
EBT Excluding Unusual Items | -22.74 | -46.67 | -111.41 | -45.9 | 70.57 | 21.44 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.84 |
Gain (Loss) on Sale of Assets | -0.01 | -3.81 | - | 0.15 | 0.17 | -0.28 |
Other Unusual Items | 0.07 | 7.16 | 3.16 | 0.01 | 0 | 0.24 |
Pretax Income | -16.89 | -43.32 | -108.25 | -45.75 | 70.74 | 22.24 |
Income Tax Expense | 7.06 | -1.16 | -13.47 | 5.02 | 10.58 | 0.86 |
Net Income | -23.95 | -42.16 | -94.78 | -50.76 | 60.16 | 21.38 |
Net Income to Common | -23.95 | -42.16 | -94.78 | -50.76 | 60.16 | 21.38 |
Net Income Growth | - | - | - | - | 181.38% | - |
Shares Outstanding (Basic) | 41 | 40 | 40 | 39 | 35 | 35 |
Shares Outstanding (Diluted) | 41 | 40 | 40 | 39 | 35 | 35 |
Shares Change (YoY) | 3.13% | - | 2.61% | 10.01% | 0.21% | 0.19% |
EPS (Basic) | -0.58 | -1.05 | -2.37 | -1.30 | 1.70 | 0.60 |
EPS (Diluted) | -0.58 | -1.05 | -2.37 | -1.30 | 1.69 | 0.60 |
EPS Growth | - | - | - | - | 179.47% | - |
Free Cash Flow | 31.78 | -62.03 | -88.11 | -12.27 | 84.17 | -57.46 |
Free Cash Flow Per Share | 0.77 | -1.55 | -2.20 | -0.31 | 2.37 | -1.62 |
Dividend Per Share | - | - | - | - | 0.769 | 0.157 |
Dividend Growth | - | - | - | - | 389.31% | - |
Gross Margin | 21.98% | 19.14% | 10.81% | 14.02% | 19.09% | 19.09% |
Operating Margin | -3.27% | -14.88% | -29.28% | -11.75% | 5.67% | 2.24% |
Profit Margin | -4.43% | -9.29% | -24.46% | -9.20% | 4.89% | 2.63% |
Free Cash Flow Margin | 5.88% | -13.66% | -22.74% | -2.22% | 6.84% | -7.06% |
EBITDA | -0.78 | -50.78 | -97.81 | -50.38 | 83.11 | 31.65 |
EBITDA Margin | -0.14% | -11.19% | -25.25% | -9.13% | 6.75% | 3.89% |
D&A For EBITDA | 16.92 | 16.76 | 15.64 | 14.46 | 13.27 | 13.43 |
EBIT | -17.7 | -67.54 | -113.45 | -64.85 | 69.84 | 18.22 |
EBIT Margin | -3.27% | -14.88% | -29.28% | -11.75% | 5.67% | 2.24% |
Effective Tax Rate | - | - | - | - | 14.96% | 3.85% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.